27
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro

, , , &
Pages 483-490 | Published online: 02 Jul 2009
 

Abstract

PURPOSE. The retinal pigment epithelium (RPE) is involved in the pathogenesis of age-related macular degeneration. The purpose of this study was to assess the effect of thalidomide, octreotide, and prednisolone on the proliferation and migration of bovine RPE cells in vitro. METHODS. The migration assay was performed in double-chamber-wells separated by a membrane filter with 8 µm pores. Cells were allowed to migrate vertically for 7 hr, afterwards the cells on both filtersides were fixed, stained, and the migrated cells were counted. To examine RPE proliferation, bovine RPE cells were seeded subconfluently followed by an incubation with octreotide, thalidomide or prednisolone in a concentration gradient for 24 hr. Stimulation or inhibition of DNA synthesis was measured by [ 3 H]-thymidine incorporation. Statistical analysis was performed with the paired student's t-test. RESULTS. Statistically significant (p < 0.05) inhibition of RPE cell proliferation was measured for thalidomide at a concentration of 10–50 µg/ml, for octreotide at a concentration of 5 × 10 -4 and 5 × 10 -5 M, and for prednisolone at a concentration of 250 and 500 µg/ml as compared to the negative control. RPE cell migration was significantly (p < 0.05) inhibited by thalidomide at a concentration of 10 µg/ml, by octreotide at a concentration of 5 × 10 -5 M, and also by prednisolone at a concentration of 500 µg/ml as compared to the negative control. CONCLUSIONS. Although the main effect of thalidomide, octreotide, and prednisolone when treating patients with choroidal neovascular membranes is probably related to the inhibition of angiogenesis it should be kept in mind that these substances may additionally inhibit RPE proliferation and migration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.